INS and Alzheimer disease: The regulation of insulin and glucose homeostasis by 26RFa and adropin has been heavily reported [191,192,193,194], and so abnormal control of insulin release by neuropeptides may play a central role in the dysfunction of metabolic regulation and energy homeostasis in obesity, as well as in the onset of cognitive decline observed in AD patients.